Literature DB >> 18768491

Discovery of novel biomarkers in oral submucous fibrosis by microarray analysis.

Ning Li1, Xinchun Jian, Yanjia Hu, Chunjiao Xu, Zhigang Yao, Xiaohuan Zhong.   

Abstract

Oral submucous fibrosis (OSF) is a high-risk precancerous condition of the oral cavity. Areca nut chewing is its key etiologic factor, but the full pathogenesis is still obscure. In this study, microarray analysis was used to characterize the mRNA changes of 14,500 genes in four OSF and four normal buccal mucosa samples to identify novel biomarkers of OSF. Five candidate genes with the most differential changes were chosen for validation. The correlation between clinicopathologic variables of 66 OSF patients and the expression of each gene was assessed by immunohistochemistry. The microarray analysis showed that 661 genes were up-regulated (fold value >2) and 129 genes were down-regulated (fold value <0.5) in OSF (q < 0.01). The top three up-regulated genes [Loricrin, Cartilage oligomeric matrix protein (COMP), Cys-X-Cys ligand 9 (CXCL9)] with the largest fold changes and the top two down-regulated genes [keratin 19 (KRT19), cytochrome P450 3A5 (CYP 3A5)] with the most significantly differential changes in OSF were chosen as candidate biomarkers. In immunohistochemical results, the expression of Loricrin and COMP showed statistically significant association with histologic grade of OSF (P = 0.03 and 0.006, respectively). COMP was found to be overexpressed frequently in patients with the habit of areca nut chewing for more than 4 years (P = 0.002). CYP 3A5 was revealed an inverse correlation with histologic grade (P = 0.04). This pilot study showed that five novel genes might play important roles in the pathogenesis of OSF and may be clinically useful for early detection of OSF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768491     DOI: 10.1158/1055-9965.EPI-07-2908

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

1.  Cys-X-Cys ligand 9 might be an immunological factor in the pathogenesis of oral submucous fibrosis and its concomitant oral lichenoid lesion.

Authors:  Ning Li; Qiong Hu; Canhua Jiang; Feng Guo; Krishna Munnee; Xinchun Jian; Yanjia Hu; Zhangui Tang
Journal:  Clin Oral Investig       Date:  2012-07-21       Impact factor: 3.573

Review 2.  Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Authors:  Jeff S Isenberg; Gema Martin-Manso; Justin B Maxhimer; David D Roberts
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

3.  Loricrin expression and its implication in oral submucous fibrosis, hyperkeratosis and normal mucosa with association to habits - An immunohistochemical study.

Authors:  Nithya S; Elizabeth Joshua; Ranganathan K; Rooban Thavarajah; Umadevi K Rao
Journal:  J Oral Biol Craniofac Res       Date:  2019-05-20

Review 4.  Loricrin - an overview.

Authors:  S Nithya; T Radhika; Nadeem Jeddy
Journal:  J Oral Maxillofac Pathol       Date:  2015 Jan-Apr

Review 5.  Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review.

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Clin Med Insights Oncol       Date:  2013-10-31

6.  Cytokeratin 19 expression patterns of dentigerous cysts and odontogenic keratocysts.

Authors:  K P Kamath; M Vidya
Journal:  Ann Med Health Sci Res       Date:  2015 Mar-Apr

7.  Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.

Authors:  Wen Liu; Lijuan Zeng; Ning Li; Fei Wang; Canhua Jiang; Feng Guo; Xinqun Chen; Tong Su; Chunjiao Xu; Shanshan Zhang; Changyun Fang
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

8.  Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.

Authors:  Shadavlonjid Bazarsad; Xianglan Zhang; Ki-Yeol Kim; Rasika Illeperuma; Ruwan D Jayasinghe; Wanninayake M Tilakaratne; Jin Kim
Journal:  J Oral Pathol Med       Date:  2016-08-06       Impact factor: 4.253

9.  An immunohistochemical study of p53 expressions in oral submucous fibrosis.

Authors:  Sandesh Manjunath; C Girish Himadal; Darshan Devang Divakar; Shaista Haleem; Hussain Ahmed Mohammad Faqeeh; Mohammed Yahya M Alshadidi
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

10.  The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.

Authors:  Minal Chaudhary; Shree Bajaj; Shruti Bohra; Nisu Swastika; Alka Hande
Journal:  J Oral Maxillofac Pathol       Date:  2015 May-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.